drug · small molecule
camonsertib
Phase 2updated 3mo agoby XenoTherapeutics Inc🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying camonsertib
- phase2Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- phase2A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)
- phase2Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors
- phase2Study of RP-3500, Camonsertib, in Advanced Solid Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 24m ago
Found something off?
comments(0)
5-min edit window · permanent after that